Intrathecal immunoselective nanopheresis for alzheimer’s disease: what and how? Why and when?

dc.contributor.author	Menéndez González, Manuel
dc.date.accessioned	2025-02-07T07:22:56Z
dc.date.available	2025-02-07T07:22:56Z
dc.date.issued	2024
dc.identifier.citation	International Journal of Molecular Sciences, 25(19), (2024); doi:10.3390/ijms251910632
dc.identifier.issn	1661-6596
dc.identifier.uri	https://hdl.handle.net/10651/76851
dc.description.sponsorship	Instituto de Salud Carlos III (ISCIII) by project DTS22/00071 and co-funded by the European Union
dc.language.iso	eng
dc.relation.ispartof	International Journal of Molecular Sciences
dc.rights	© 2024 by the author
dc.rights	CC Reconocimiento 4.0 Internacional
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scopus
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85206482743&doi=10.3390%2fijms251910632&partnerID=40&md5=cf75e1fee12738c7beb62315a569652a
dc.title	Intrathecal immunoselective nanopheresis for alzheimer’s disease: what and how? Why and when?
dc.type	journal article
dc.identifier.doi	10.3390/ijms251910632
dc.relation.projectID	DTS22/00071
dc.relation.publisherversion	http://dx.doi.org/10.3390/ijms251910632
dc.rights.accessRights	open access
dc.type.hasVersion	VoR

Este ítem está sujeto a una licencia Creative Commons